Phase III trial of recombinant interferon gamma in complete responders with small-cell lung cancer. [electronic resource]
Producer: 19941202Description: 2321-6 p. digitalISSN:- 0732-183X
- Adult
- Aged
- Blood Platelet Disorders -- etiology
- Carcinoma, Small Cell -- mortality
- Combined Modality Therapy
- Dose-Response Relationship, Drug
- Female
- Humans
- Interferon-gamma -- adverse effects
- Lung Neoplasms -- mortality
- Male
- Middle Aged
- Multivariate Analysis
- Patient Compliance
- Platelet Count
- Recombinant Proteins
- Remission Induction
- Survival Analysis
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.